1. Home
  2. SBSI vs VIR Comparison

SBSI vs VIR Comparison

Compare SBSI & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Southside Bancshares Inc.

SBSI

Southside Bancshares Inc.

HOLD

Current Price

$30.58

Market Cap

936.3M

Sector

Finance

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$9.54

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBSI
VIR
Founded
1960
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
936.3M
1.0B
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
SBSI
VIR
Price
$30.58
$9.54
Analyst Decision
Hold
Strong Buy
Analyst Count
2
8
Target Price
$35.50
$19.63
AVG Volume (30 Days)
95.0K
3.9M
Earning Date
04-30-2026
01-01-0001
Dividend Yield
4.61%
N/A
EPS Growth
N/A
17.49
EPS
2.29
N/A
Revenue
N/A
$68,556,000.00
Revenue This Year
$28.87
N/A
Revenue Next Year
$5.82
$925.73
P/E Ratio
$13.68
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.85
$4.16
52 Week High
$34.37
$10.91

Technical Indicators

Market Signals
Indicator
SBSI
VIR
Relative Strength Index (RSI) 34.49 62.18
Support Level $27.73 $4.95
Resistance Level $31.60 $10.91
Average True Range (ATR) 0.79 0.69
MACD -0.21 0.07
Stochastic Oscillator 14.02 62.69

Price Performance

Historical Comparison
SBSI
VIR

About SBSI Southside Bancshares Inc.

Southside Bancshares Inc is a bank holding company. Through its subsidiary, the Southside Bank, it operates as a financial institution offering various financial services to individuals, businesses, municipal entities, and nonprofit organizations. These services include consumer and commercial loans, deposit accounts, wealth management and trust services, brokerage services, and safe deposit services. The company's primary market areas are East Texas, Southeast Texas, and the greater Dallas-Fort Worth, Austin, and Houston, Texas.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: